Neuronetics Stockholders Vote on Directors and Executive Compensation

TL;DR

Neuronetics shareholders re-elected directors and approved executive pay.

AI Summary

On May 30, 2024, Neuronetics, Inc. announced the results of its 2024 Annual Meeting of Stockholders. The company's stockholders voted to elect three Class II directors, re-appoint PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2024, and approve, on an advisory basis, the compensation of its named executive officers.

Why It Matters

The outcome of the annual meeting confirms the company's board of directors and auditor, providing stability and continuity for Neuronetics' operations.

Risk Assessment

Risk Level: low — This filing reports routine corporate governance matters, such as director elections and auditor appointments, which typically carry low risk.

Key Players & Entities

• Neuronetics, Inc. (company) — Registrant
• PricewaterhouseCoopers LLP (company) — Independent registered public accounting firm

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock ($0.01 par value) STIM The Nasdaq Global M

Filing Documents

• d815093d8k.htm (8-K) — 31KB
• 0001193125-24-153005.txt ( ) — 147KB
• stim-20240530.xsd (EX-101.SCH) — 3KB
• stim-20240530_lab.xml (EX-101.LAB) — 17KB
• stim-20240530_pre.xml (EX-101.PRE) — 11KB
• d815093d8k_htm.xml (XML) — 3KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 30, 2024 NEURONETICS, INC. (Exact name of registrant as specified in its charter) Delaware 001-38546 33-1051425 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 3222 Phoenixville Pike , Malvern , PA 19355 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (610) 640-4202 (Former name or former address, if changed since last report.) Not applicable. Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol (s) Name on each exchange on which registered Common Stock ($0.01 par value) STIM The Nasdaq Global Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.07 Submission of Matters to a Vote of Security Holders Neuronetics, Inc. (the "Company") held its Annual Meeting of Stockholders on May 30, 2024 (the "Annual Meeting"). A total of 23,160,764 shares of common stock, representing approximately 77.26% of the shares outstanding and eligible to vote and constituting a quorum, were represented in person or by valid proxies at the Annual Meeting. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2025 Annual Meeting, or until their respective successors are elected and qualified, by the votes set forth in the table below: Nominees For Withheld Broker Non-Votes Robert A. Cascella 17,030,474 682,887 5,447,403 Sheryl L. Conley 15,346,682 2,366,679 5,447,403 Glenn P. Muir 17,678,156 35,205 5,447,403 Megan Rosengarten 15,580,509 2,132,852 5,447,403 Keith J. Sullivan 17,635,574 77,787 5,447,403 Proposal 2: The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified by the Company's stockholders by the votes set forth in the table below: 20,820,189 votes FOR the proposal 2,340,133 votes AGAINST the proposal 442 votes ABSTAIN Proposal 3: The approval, on a non-binding, advisory basis, of the compensation of the individual who served as our principal executive officer during 2023 and our two other most highly compensated executive officers who were serving as executive officers as of December 31, 2023 (collectively, our "Named Executive Officers") was ratified by the Company's stockholders by the votes set forth in the table below: 12,125,947 votes FOR the proposal 5,576,257 votes AGAINST the proposal 11,157 votes ABSTAIN 5,447,403 votes Broker Non-Votes Proposal 4: The approval, on a non-binding, advisory basis, of the frequency of future stockholder advisory votes on the compensation of our Named Executive Officers was ratified by the Company's stockholders by the votes set forth in the table below: 17,435,845 votes 1 Year 2,162 votes 2 Years 248,764 votes 3 Years 26,590 votes Abstain SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEURONETICS, INC. (Registrant) Date: June 3, 2024 By: /s/ W. Andrew Macan Name: W. Andrew Macan Title: Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR